Dopamine Agonists, DRIs Similar for QoL in Parkinson Disease

WEDNESDAY, Dec. 29, 2021 -- For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors (DRIs), and among...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news